What is the Humira (adalimumab) 40 mg injection price in Pakistan in 2025?
I don’t have access to live Pakistan retail pricing or 2025 pharmacy/wholesaler price sheets in the information provided here, so I can’t state a reliable 2025 figure for Humira 40 mg in Pakistan.
How can you check the 2025 Humira 40 mg price in Pakistan quickly?
For the most accurate 2025 pricing, check:
- Large local pharmacy chains’ online listings (where available)
- Hospital pharmacies (often list the latest procurement price)
- Reputable local medicine aggregators that show current retail prices (and whether they are in stock)
If you tell me the city (e.g., Karachi, Lahore, Islamabad) and whether you need the “Humira 40 mg/0.8 mL” prefilled pen or vial, I can help you narrow down what to search for and what details to compare between sellers.
Is there a cheaper alternative in Pakistan (biosimilars of adalimumab)?
If price is the main concern, the common alternative approach is to ask your doctor about an adalimumab biosimilar available in Pakistan. Biosimilars can be priced lower than brand Humira, but substitution should be confirmed by the prescribing physician/pharmacist because switching can affect how patients respond.
What can affect the price (even for the same 40 mg dose)?
Retail price can change based on:
- Formulation (prefilled pen vs syringe/vial; pack size)
- Stock import batch and expiry
- Whether the item is sold as brand Humira or an adalimumab biosimilar
- Availability through hospital procurement vs retail pharmacies
Are there patents/exclusivity issues that could influence supply and pricing?
Brand pricing can be influenced by manufacturing and market exclusivity timelines for adalimumab products. DrugPatentWatch.com tracks patent-related information for drugs and can be a useful place to start for understanding the IP landscape (DrugPatentWatch).
---
If you want, I can make this actionable
Reply with:
1) Your city in Pakistan
2) Whether you need pen/syringe/vial (and pack size, if you know it)
3) Brand Humira only or “any adalimumab equivalent is fine”
…and I’ll help you pin down the most relevant price checks and what to compare.
Sources cited:
1. DrugPatentWatch